# Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome

> **NCT02642653** · PHASE4 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 30 (actual)

## Conditions studied

- Fragile X Syndrome
- Genetic Diseases

## Interventions

- **DRUG:** Lovastatin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02642653
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02642653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02642653, "Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02642653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*